Accidental selection and intentional restoration of sporulation-deficient Bacillus anthracis mutants.

Applied and Environmental Microbiology
Inka SastallaStephen H Leppla

Abstract

We demonstrate the frequent accidental enrichment of spontaneous sporulation-deficient mutants of Bacillus anthracis on solid medium and identify contributing factors. Mutations in spo0A, encoding the master regulator of sporulation initiation, were found in 38 of 53 mutants. Transductions using bacteriophage CP51 propagated on sporogenic bacteria allowed for the restoration of sporulation phenotypes.

References

Dec 1, 1976·Bacteriological Reviews·P J Piggot, J G Coote
Jan 1, 1977·Annual Review of Genetics·R A Weisberg, S Adhya
Jan 1, 1976·Advances in Genetics·J A Hoch
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M StrauchJ A Hoch
May 1, 1986·Infection and Immunity·B E IvinsS H Leppla
Aug 1, 1985·Infection and Immunity·B D GreenB E Ivins
Jul 1, 1968·Journal of Virology·C B Thorne
Mar 1, 1970·The Journal of Applied Bacteriology·H IonescoP Schaeffer
Dec 15, 1993·Gene·S D EhrlichB Michel
Apr 4, 2000·Current Opinion in Microbiology·J A Hoch
Jun 28, 2000·Proceedings of the National Academy of Sciences of the United States of America·P FawcettP Youngman
Jul 10, 2001·Letters in Applied Microbiology·M A Idachaba, P L Rogers
Dec 4, 2003·Molecular Microbiology·Virginie MolleRichard Losick
Dec 22, 2005·Infection and Immunity·Andrei P PomerantsevStephen H Leppla
Feb 24, 2006·Infection and Immunity·Brian K Janes, Scott Stibitz
Feb 3, 2009·Applied and Environmental Microbiology·Inka SastallaStephen H Leppla
Jun 9, 2009·Journal of Bacteriology·Andrei P PomerantsevStephen H Leppla
Sep 5, 2009·Molecular Aspects of Medicine·Paul KeimRichard Okinaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Infection and Immunity
Andrei P PomerantsevStephen H Leppla
Science
José E González-PastorRichard Losick
© 2021 Meta ULC. All rights reserved